2010
DOI: 10.1111/j.1442-9071.2010.02240.x
|View full text |Cite
|
Sign up to set email alerts
|

Antituberculosis medication as a possible epigenetic factor of Leber's hereditary optic neuropathy

Abstract: Antituberculosis medication may be an epigenetic factor of LHON in patients with a primary LHON mutation. This risk should be recognized by physicians and LHON carriers.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
18
0
2

Year Published

2013
2013
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(21 citation statements)
references
References 14 publications
(14 reference statements)
1
18
0
2
Order By: Relevance
“…Ethambutol and erythromycin have also been suggested to trigger LHON (85)(86)(87). Similarly, ethambutol has been linked to visual loss in a patient with dominant optic atrophy (DOA) with an OPA1 mutation (88).…”
Section: Genetic Mitochondrial Dysfunction Predisposes Patients To Grmentioning
confidence: 98%
“…Ethambutol and erythromycin have also been suggested to trigger LHON (85)(86)(87). Similarly, ethambutol has been linked to visual loss in a patient with dominant optic atrophy (DOA) with an OPA1 mutation (88).…”
Section: Genetic Mitochondrial Dysfunction Predisposes Patients To Grmentioning
confidence: 98%
“…Indeed, cases of LHON-related vision loss have been reported in patients taking ethambutol, with some authors postulating that ethambutol may be an epigenetic trigger for LHON. 4 Although this remains controversial, with some authors finding no synergism between the two, LHON should be considered in atypical cases of EON, including those with early disc hyperaemia, severe late optic atrophy, continuing visual decline following ethambutol cessation, and advanced age at onset, as in our cases. [4][5][6] Furthermore, ethambutol has been associated with cases of OPA1-related optic atrophy and one case of CMT2A2-related optic atrophy with systemic signs of muscle weakness.…”
Section: Discussionmentioning
confidence: 68%
“…4 Although this remains controversial, with some authors finding no synergism between the two, LHON should be considered in atypical cases of EON, including those with early disc hyperaemia, severe late optic atrophy, continuing visual decline following ethambutol cessation, and advanced age at onset, as in our cases. [4][5][6] Furthermore, ethambutol has been associated with cases of OPA1-related optic atrophy and one case of CMT2A2-related optic atrophy with systemic signs of muscle weakness. [7][8][9] With differing pathophysiology, LHON impairing oxidative phosphorylation, whilst OPA1 and CMT2A2 disturbing mitochondrial fusion, these reports strengthen the suggestion of an epigenetic, or synergistic, effect between mitochondrial genetics and ethambutol in the development of EON or optic atrophy.…”
Section: Discussionmentioning
confidence: 68%
“…An onset of LHON can be not only associated with but also triggered by many factors, including diabetes, 11,21 optic neuritis, 22 anti-tuberculous medications, 10,23,24 antiretroviral therapy for human immunodeficiency virus, 25,26 carbon monoxide poisoning, 27 solvent exposure, 28 smoking, 1,11,14,2931 trauma, 11,12,14,32,33 and even an increase in the intraocular pressure. 11,12 For example, a 58-year-old man had an onset of visual loss 1 year after an elevation in his intraocular pressures was first recorded, and a 11778G→A mutation was identified.…”
Section: Discussionmentioning
confidence: 99%